本期内容提示:
1、一大波核心仓位出现建仓机会,优先考虑哪些?
2、又一只有翻倍潜力的成长股临近理想建仓区;
3、$Rxi Pharmaceuticals Corp(PHIO)$ 数据不错,可否追涨?
$恒瑞医药(SH600276)$ $华东医药(SZ000963)$查看全文
Replix锐璞美股2021-03-01 21:16
$Phio Pharmaceuticals(PHIO)$ PHIO PHARMACEUTICALS AND AGONOX, INC. ANNOUNCE COLLABORATION ON CLINICAL DEVELOPMENT OF NOVEL T CELL-BASED CANCER IMMUNOTHERAPIES
Under the terms of the collaboration agreement, AgonOx will receive financial support for the clinical trial from...查看全文
Replix锐璞美股2021-02-18 14:08
$Phio Pharmaceuticals(PHIO)$ 公司增发完毕,看看是否能翻身。
$基因进化ETF-ARK(ARKG)$ $富途控股(FUTU)$查看全文
$Phio Pharmaceuticals(PHIO)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-20-044916 Act: 34 Size: 105 KB 网页链接
$Phio Pharmaceuticals(PHIO)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0000919574-20-002821 Act: 34 Size: 117 KB 网页链接
$Phio Pharmaceuticals(PHIO)$ 8-K Current report, items 1.01, 3.02, and 9.01 Accession Number: 0001683168-20-001071 Act: 34 Size: 600 KB 网页链接
$Phio Pharmaceuticals(PHIO)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001683168-20-001063 Act: 33 Size: 341 KB 网页链接
$Phio Pharmaceuticals(PHIO)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001683168-20-000969 Act: 34 Size: 3 MB 网页链接
$Phio Pharmaceuticals(PHIO)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001683168-20-000971 Act: 34 Size: 83 KB 网页链接
$Phio Pharmaceuticals(PHIO)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001683168-20-000783 Act: 34 Size: 37 KB 网页链接
$Phio Pharmaceuticals(PHIO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-015801 Size: 5 KB 网页链接
$Phio Pharmaceuticals(PHIO)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001683168-20-000630 Act: 33 Size: 51 KB 网页链接
$Phio Pharmaceuticals(PHIO)$ D Notice of Exempt Offering of Securities, item 06b Accession Number: 0001683168-20-000567 Act: 33 Size: 13 KB 网页链接